Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Castaman

Showing results (111-120 of 198) with videos related to

Pageof 20
Sort By:
American Journal of Hematology|December 1, 1993
Multimeric pattern of plasma and platelet von Willebrand factor is normal in uremic patientsG Castaman, F Rodeghiero, A Lattuada, et al.
Comptes Rendus De L'Academie Des Sciences. Serie III, Sciences De La Vie|October 1, 1993
Ex vivo experimental thrombosis in variants of von Willebrand diseaseE Fressinaud, A B Federici, G Castaman, et al.
British Journal of Haematology|January 29, 2000
Heightened proteolysis of the von Willebrand factor subunit in patients with von Willebrand disease hemizygous or homozygous for the C2362F mutationG Castaman, J C Eikenboom, A Lattuada, et al.
Acta Haematologica|January 1, 1987
Recurrent life-threatening epistaxis in a child with Bernard-Soulier syndrome controlled by bilateral ligation of external carotids and ethmoidal arteriesF Rodeghiero, G Castaman, G Pesavento, et al.
Blood|May 16, 1998
Molecular mechanisms of type II factor XIII deficiency: novel Gly562-Arg mutation and C-terminal truncation of the A subunit cause factor XIII deficiency as characterized in a mammalian expression systemN Takahashi, H Tsukamoto, H Umeyama, et al.
American Journal of Hematology|August 1, 1995
Platelet von Willebrand factor abnormalities in myeloproliferative syndromesG Castaman, A Lattuada, M Ruggeri, et al.
Blood|October 9, 1998
Treatment of acquired von Willebrand syndrome in patients with monoclonal gammopathy of uncertain significance: comparison of three different therapeutic approachesA B Federici, F Stabile, G Castaman, et al.
Thrombosis and Haemostasis|May 6, 1998
Characterization of the genetic defects in recessive type 1 and type 3 von Willebrand disease patients of Italian originJ C Eikenboom, G Castaman, H L Vos, et al.
Haematologica|January 4, 1998
Pilot study on the safety and efficacy of desmopressin for the treatment or prevention of bleeding in patients with hematologic malignanciesG Castaman, E D Bona, C Schiavotto, et al.
Journal of Thrombosis and Haemostasis : JTH|January 20, 2006
Factor VIII and von Willebrand factor changes after desmopressin and during pregnancy in type 2M von Willebrand disease Vicenza: a prospective study comparing patients with single (R1205H) and double (R1205H-M740I) defectG Castaman, A B Federici, M Bernardi, et al.
Pageof 20

Showing results (111-120 of 198) with videos related to

Sort By:
Pageof 20
American Journal of Hematology|December 1, 1993
Multimeric pattern of plasma and platelet von Willebrand factor is normal in uremic patientsG Castaman, F Rodeghiero, A Lattuada, et al.
Comptes Rendus De L'Academie Des Sciences. Serie III, Sciences De La Vie|October 1, 1993
Ex vivo experimental thrombosis in variants of von Willebrand diseaseE Fressinaud, A B Federici, G Castaman, et al.
British Journal of Haematology|January 29, 2000
Heightened proteolysis of the von Willebrand factor subunit in patients with von Willebrand disease hemizygous or homozygous for the C2362F mutationG Castaman, J C Eikenboom, A Lattuada, et al.
Acta Haematologica|January 1, 1987
Recurrent life-threatening epistaxis in a child with Bernard-Soulier syndrome controlled by bilateral ligation of external carotids and ethmoidal arteriesF Rodeghiero, G Castaman, G Pesavento, et al.
Blood|May 16, 1998
Molecular mechanisms of type II factor XIII deficiency: novel Gly562-Arg mutation and C-terminal truncation of the A subunit cause factor XIII deficiency as characterized in a mammalian expression systemN Takahashi, H Tsukamoto, H Umeyama, et al.
American Journal of Hematology|August 1, 1995
Platelet von Willebrand factor abnormalities in myeloproliferative syndromesG Castaman, A Lattuada, M Ruggeri, et al.
Blood|October 9, 1998
Treatment of acquired von Willebrand syndrome in patients with monoclonal gammopathy of uncertain significance: comparison of three different therapeutic approachesA B Federici, F Stabile, G Castaman, et al.
Thrombosis and Haemostasis|May 6, 1998
Characterization of the genetic defects in recessive type 1 and type 3 von Willebrand disease patients of Italian originJ C Eikenboom, G Castaman, H L Vos, et al.
Haematologica|January 4, 1998
Pilot study on the safety and efficacy of desmopressin for the treatment or prevention of bleeding in patients with hematologic malignanciesG Castaman, E D Bona, C Schiavotto, et al.
Journal of Thrombosis and Haemostasis : JTH|January 20, 2006
Factor VIII and von Willebrand factor changes after desmopressin and during pregnancy in type 2M von Willebrand disease Vicenza: a prospective study comparing patients with single (R1205H) and double (R1205H-M740I) defectG Castaman, A B Federici, M Bernardi, et al.
Pageof 20